ClinConnect ClinConnect Logo
Search / Trial NCT01984112

Proximal Humerus Fractures: Randomized Study Between Locking Nails and Locking Plates for Neer 2 and 3 Parts

Launched by UNIVERSITY OF SAO PAULO · Nov 7, 2013

Trial Information

Current as of June 13, 2025

Completed

Keywords

Humerus Fracture Nail Plate Tuberosity

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Fracture with less than 21 days;
  • Fractures of the proximal humerus classified as 2 or 3 parts of Neer, with involvement of the humeral head and one of the tuberosities;
  • Fracture with unacceptable deviation for the non-surgical treatment, according to the criteria of Neer Neer: fractures with deviation greater than 45 ° or 1 cm for the fragment of the humeral head and fractures with a deviation of the tuberosity greater than 0.5 cm;
  • Closed fractures;
  • Exclusion Criteria:
  • * Characteristics of the fracture:
  • fracture between the greater tubercle and the smaller, independent of the deviation;
  • Isolated fracture of the greater or lesser tuberosity
  • 4-part fractures of Neer;
  • Fracture involving the articular surface of the humeral head;
  • Fracture-dislocation of the proximal humerus
  • * Other criteria:
  • Neurological injuries in the affected limb;
  • previous surgery on the affected shoulder;
  • associated fractures in the affected limb;
  • pathologic fractures;
  • lesions of the rotator cuff tendons previously diagnosed;
  • Psychiatric illnesses or inability to understand preoperative questionnaires;
  • Active infection or previous infection on the shoulder;

About University Of Sao Paulo

The University of São Paulo (USP) is a prestigious public research university located in Brazil, renowned for its commitment to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, USP leverages its extensive academic resources, interdisciplinary expertise, and state-of-the-art facilities to facilitate groundbreaking research aimed at improving patient outcomes and addressing critical health challenges. The university's strong emphasis on ethical standards and regulatory compliance ensures that all clinical trials are conducted with the highest integrity, fostering collaboration among researchers, healthcare professionals, and the broader community to enhance scientific discovery and translate findings into practical applications.

Locations

São Paulo, Sp, Brazil

Patients applied

0 patients applied

Trial Officials

Mauro EC Gracitelli, MD

Principal Investigator

University of Sao Paulo

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials